The Covid-19 pandemic’s effect on Private Equity transactions in Norway.

Despite the lower level of activity resulting from the COVID-19 pandemic, Norwegian M&A could return to higher levels of deal volume once there is more certainty around the ramifications of the virus on businesses and the Norwegian economy. Ole Kristian Aabø-Evensen, partner and lawyer at Aabø-Evensen, expect continuing strong momentum for new Private Equity deals within particular sectors, such as TMT, healthcare, pharmaceuticals and industrials and manufacturing.

On the other hand, the COVID-19 pandemic is also likely to result in an increasing number of insolvency cases, particularly in industries such as travel, tourism and retail. This will create a number of opportunistic opportunities for investors looking to invest within these industries long-term.

Read more about this, and about legal issues that can arise within Private Equity transactions in Norway today, in the Norwegian chapter of the latest issue of the publication The International Comparative Legal Guide to: Private Equity  - a practical cross-border overview of legal issues within private equity.

Contact
Ole K. Aabø-Evensen
(+47) +47 477 81 840
oka@aaboevensen.com

Fill out the form and download the publication